Clinical data | |
---|---|
Routes of administration | Oral |
Drug class | Sympathomimetic; β3-Adrenergic receptor agonist |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C27H29NO |
Molar mass | 383.535 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Trecadrine (INNTooltip International Nonproprietary Name) is a drug that was originally developed as an anti-ulcer agent but was found to act as a β3-adrenergic receptor agonist with potential anti-obesity and anti-diabetic properties. It is selective for the β3-adrenergic receptor, lacking activity at the β1- and β2-adrenergic receptors. The drug is orally active. Structurally, trecadrine is a substituted β-hydroxyamphetamine and derivative of β-hydroxy-N-methylamphetamine (ephedrine, pseudoephedrine) with a tricyclic moiety attached at the amine.
References
- ^ Hu B, Jennings LL (2003). "Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes". Progress in Medicinal Chemistry. 41: 167–194. doi:10.1016/s0079-6468(02)41005-3. ISBN 978-0-444-51142-3. PMID 12774694.
- ^ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. pp. 411, 571. ISBN 978-1-4757-2085-3. Retrieved 17 October 2024.
- Milne GW (2002). Drugs: Synonyms and Properties. Wiley. p. 514. ISBN 978-0-566-08491-1. Retrieved 17 October 2024.
- "-drine sympathomimetics" (PDF). The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances 2018 (Stem Book 2018). World Health Organization.
- "CID 65823". PubChem. U.S. National Library of Medicine. Retrieved 17 October 2024.
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Tricyclics | |
---|---|
Classes | |
Antidepressants (Tricyclic antidepressants (TCAs)) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Anticholinergics | |
Others |